Search results for "DOMAIN"

showing 10 items of 2485 documents

Ciencia de la Sostenibilidad: ¿Una nueva disciplina o un nuevo enfoque para todas las disciplinas?

2015

Al inicio de este siglo XXI comenzó a desarrollarse un nuevo dominio científico, la Ciencia de la Sostenibilidad, con el objetivo explícito de hacer frente a la actual situación de emergencia planetaria e impulsar la transición a sociedades sostenibles. Una nueva forma de hacer ciencia para un nuevo período de la historia de la humanidad, el Antropoceno, en el que el planeta está experimentando grandes cambios, debidos principalmente a la acción de los seres humanos, que amenazan la supervivencia de la propia especie humana. Nuestro propósito en este trabajo ha sido analizar en qué medida esta Ciencia de la Sostenibilidad puede realmente contribuir a la necesaria transición a la Sostenibili…

media_common.quotation_subjectRelaciones Ciencia-Tecnología-Sociedad-Ambiente (CTSA)Emergencia planetarialcsh:Education (General)AnthropoceneCiencia de la SostenibilidadPedagogiamedia_commonbusiness.industryConstitutionSustainability scienceciencias de la naturalezaEnvironmental ethicsGeneral Medicinerama de estudiosGeographyEnvironmental educationScientific domainHumanitySustainabilityeducación ambientalEducación para la Sostenibilidadbusinesslcsh:L7-991CartographyDisciplineestudio del medio ambienteRevista Iberoamericana de Educación
researchProduct

Empirical Mode Decomposition on Mismatch Negativity

2008

Empirical mode decomposition (EMD) has been applied in the various disciplines to extract the desired signal. The basic principle is to decompose a time series into intrinsic mode functions (IFMs) and each IFM corresponds to an oscillation phenomenon. A statistical description of the oscillatory activities of the EEG has been well known. It is desired to extract single oscillatory process from the EEG by EMD. Mismatch negativity (MMN) can be automatically elicited by the deviant stimulus in an oddball paradigm, in which physically the deviant stimulus occurs among repetitive and homogeneous stimuli. MMN thus reflects the ability of the brain to detect changes in auditory stimuli. So, the MM…

medicine.diagnostic_testbusiness.industryMismatch negativityPattern recognitionElectroencephalographyHilbert–Huang transformTime–frequency analysisEvent-related potentialFrequency domainmedicineArtificial intelligenceInfomaxbusinessOddball paradigmMathematics
researchProduct

Domains of the E1 Protein of Human Papillomavirus Type 33 Involved in Binding to the E2 Protein

1996

Papillomavirus E1 and E2 proteins are essential for the initiation of viral DNA replication. We have now analyzed the interaction of E1 and E2 of human papillomavirus type 33, which is associated with cervical carcinoma. When synthesized in insect cells using the baculovirus expression system, the E1 and E2 proteins interacted efficiently at 4 degree. A monoclonal antibody recognizing E1 amino acids 584--600 inhibited the binding of E2 and vice versa, indicating that these amino acids are involved in E2 binding. To confirm this result, a mutational analysis of E1 was performed. The E2 binding activity of E1 deletion and point mutant proteins was assayed using glutathione S-transferase E1 fu…

medicine.drug_classRecombinant Fusion ProteinsMolecular Sequence DataContext (language use)BiologySpodopteraMonoclonal antibodyAntibodies ViralCell Linechemistry.chemical_compoundMiceVirologymedicineTumor Cells CulturedAnimalsHumansPoint MutationPapillomaviridaeDNA PrimersGlutathione TransferaseSequence Deletionchemistry.chemical_classificationMice Inbred BALB CBase SequencePoint mutationTemperatureAntibodies MonoclonalGlutathioneOncogene Proteins ViralFusion proteinMolecular biologyIn vitroAmino acidchemistryEpitope MappingBinding domainProtein BindingVirology
researchProduct

Comparison of frequency domain measures based on spectral decomposition for spontaneous baroreflex sensitivity assessment after Acute Myocardial Infa…

2021

Abstract The objective of this study is to present a new method to assess in the frequency domain the directed interactions between the spontaneous variability of systolic arterial pressure (SAP) and heart period (HP) from their linear model representation, and to apply it for studying the baroreflex control of arterial pressure in healthy physiological states and after acute myocardial infarction (AMI). The method is based on pole decomposition of the model transfer function and on the following evaluation of causal measures of coupling and gain from the poles associated to low frequency (0.04−0.15 Hz) oscillatory components. It is compared with traditional non-causal approaches for the sp…

medicine.medical_specialty0206 medical engineeringBiomedical EngineeringHealth Informatics02 engineering and technologyAcute myocardial infarctionBaroreflexSettore ING-INF/01 - ElettronicaMatrix decomposition03 medical and health sciences0302 clinical medicineInternal medicinemedicineSpectral analysiscardiovascular diseasesMyocardial infarctionSensitivity (control systems)Spectral decompositionbusiness.industryHead-up tiltLinear modelBaroreflexmedicine.disease020601 biomedical engineeringFrequency domainCausalityBlood pressureFrequency domainCardiovascular controlSignal ProcessingSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaCardiologybusiness030217 neurology & neurosurgery
researchProduct

An evaluation of RVX-208 for the treatment of atherosclerosis

2015

Introduction: RVX-208 is a first-in-class, orally active, novel small molecule in development by Resverlogix Corporation (Calgary, AB, Canada). It acts through an epigenetic mechanism by inhibiting the bromodomain and extraterminal (BET) family of proteins, increasing apolipoprotein A-I (apoA-I) and targeting high-density lipoprotein (HDL) metabolism, including generating of nascent HDL and increased larger HDL particles, resulting in the stimulation of reverse cholesterol transport. RVX-208 also has a beneficial effect on inflammatory factors known to be involved in atherosclerosis and plaque stability. New therapeutic strategies are needed for patients with atherosclerosis.Areas covered: …

medicine.medical_specialtyApolipoprotein Bapolipoprotein A-IRVX 208high-density lipoproteinPharmacologyEpigenesis Geneticchemistry.chemical_compoundatherosclerosiHigh-density lipoproteinMetabolic DiseasesInternal medicinemedicineAnimalsHumansPharmacology (medical)QuinazolinonesPharmacologybiologyAnimalCholesterolMedicine (all)Cholesterol HDLReverse cholesterol transportRVX-208QuinazolineGeneral MedicineAtherosclerosisPlaque AtheroscleroticMetabolic DiseaseBromodomainOrally activeEndocrinologyhigh-density lipoprotein particlechemistryQuinazolinesbiology.proteinlipids (amino acids peptides and proteins)HumanLipoproteinExpert Opinion on Investigational Drugs
researchProduct

Teaching Technology Usage in the ENT Medical Subdomain via a Flipped Classroom Approach

2018

The flipped classroom approach is supporting a continuous interaction of students and instructors via online communication and strengthens the ability to solve problems by self-organization. This is especially important in medical domains, like the one of ENT-Head/Neck (ENT: Ear-Nose-Throat) surgeries and treatment. Surgical corrections of the nasal airways, like FESS (Functional Endoscopy Sinus Surgery) or in the field of plastic surgery, are the second frequent surgical interventions in otorhinolaryngology. They have to be prepared very carefully and airflow simulation with Computational Fluid Dynamics (CFD) is gaining importance for diagnostics here. New in silico procedures, like imagin…

medicine.medical_specialtyCfd simulationComputer scienceLearning environmenteducationFlipped classroomField (computer science)Domain (software engineering)Visualization03 medical and health sciences0302 clinical medicineClinical pathwayOtorhinolaryngologyotorhinolaryngologic diseasesmedicineMedical physics030223 otorhinolaryngology030217 neurology & neurosurgeryInternational Journal of Advanced Corporate Learning (iJAC)
researchProduct

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

2020

Abstract Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of caplacizumab for a minimum of 30 days after stopping daily PEX. This study was a retrospective, observational analysis of the use of caplacizumab in 60 patients from 29 medical centers in Germany. Immunosuppressive treatment led to a rapid normalization of ADAMTS13 activities (calculated median, 21 days). In 35 of 60 patients, ADAMTS13 activities started to normalize before day 30 after PEX; in 11 of 60 patients, the treatment was…

medicine.medical_specialtyClinical Trials and Observationsmedicine.medical_treatmentMedizinADAMTS13 Protein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineVon Willebrand factorFibrinolytic AgentsInternal medicinehemic and lymphatic diseasesvon Willebrand FactormedicineHumansIn patientRetrospective StudiesAcquired Thrombotic Thrombocytopenic PurpurabiologyPurpura Thrombotic Thrombocytopenicbusiness.industryImmunosuppressionRetrospective cohort studyHematologySingle-Domain AntibodiesADAMTS13Cardiovascular and Metabolic Diseases030220 oncology & carcinogenesisbiology.proteinBiomarker (medicine)Caplacizumabbusiness
researchProduct

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

2021

Abstract The efficacy and safety of caplacizumab in individuals with acquired thrombotic thrombocytopenic purpura (aTTP) have been established in the phase 2 TITAN and phase 3 HERCULES trials. Integrated analysis of data from both trials was conducted to increase statistical power for assessing treatment differences in efficacy and safety outcomes. Caplacizumab was associated with a significant reduction in the number of deaths (0 vs 4; P < .05) and a significantly lower incidence of refractory TTP (0 vs 8; P < .05) vs placebo during the treatment period. Consistent with the individual trials, treatment with caplacizumab resulted in a faster time to platelet count response (ha…

medicine.medical_specialtyExacerbationThrombotic thrombocytopenic purpura030204 cardiovascular system & hematologyPlaceboGastroenterology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRefractoryInternal medicinemedicineHumans610 Medicine & healthAcquired Thrombotic Thrombocytopenic PurpuraPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryHazard ratioHematologySingle-Domain Antibodiesmedicine.diseaseStimulus ReportTolerability030220 oncology & carcinogenesisCaplacizumabbusinessBlood Advances
researchProduct

U-search: a meta engine for creation of knowledge paths on the web

2010

The main tools used to find digital contents in the Web are search engines and directories but they are not presently able to understand the user specific needs and starting knowledge. This work presents "U-Search" a new meta engine that allows to create knowledge paths on the Web based on specific user requirements and knowledge levels. To this end, we consider different searcher categories such as a "basic searcher" who knows little about a topic and will look for more information, a "deep searcher" who will look for specific details on a topic that he/she already knows and a "wide searcher" who will look for expanding his/her knowledge domain with topics that are loosely related to the s…

medicine.medical_specialtyInformation retrievalSettore INF/01 - InformaticaComputer scienceclustering information search and retrieval search process web engineUser requirements documentDomain (software engineering)World Wide WebSearch engineWeb pagemedicineWeb search engineCluster analysisUser needsWeb modeling
researchProduct

The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

2007

Background: Insulin receptor substrate 1 (IRS-1) is a signaling molecule that exerts a key role in mediating cross talk between estrogen receptor a (ERa) and insulin-like growth factor 1 (IGF-1) in breast cancer cells. Previously, we demonstrated that a fraction of IRS-1 binds ERa, translocates to the nucleus, and modulates ERa-dependent transcription at estrogen response elements (ERE). Here, we studied structure-function relationships of the ER-a:IRS-1 complex under IGF-1 and/or estradiol (E 2 ) stimulation. Materials and methods: ERa and IRS-1 deletion mutants were used to analyze structural and functional ERα/IRS-1 interactions. IRS-1 binding to ERE and IRS-1 role in ERa-dependent ERE t…

medicine.medical_specialtyInsulin Receptor Substrate ProteinsActive Transport Cell NucleusEstrogen receptorRepressorBreast NeoplasmsBiologyStructure-Activity Relationshipestrogen receptor alpha (ERa) Insulin receptor substrate 1 (IRS-1) breast cancerCell Line TumorInternal medicineCoactivatormedicineHumansInsulin-Like Growth Factor IReceptors InterferonEstradiolEstrogen Receptor alphaHematologyDNA-binding domainPhosphoproteinsPeptide FragmentsReceptor InsulinProtein Structure TertiaryCell biologyIRS1Repressor ProteinsPleckstrin homology domainEndocrinologyOncologyInsulin Receptor Substrate ProteinsFemaleChromatin immunoprecipitationProtein BindingAnnals of Oncology
researchProduct